Chiltern Announces Early Phase Partnership With Tayside Academic Health Sciences Centre

LONDON, June 2, 2010 - Chiltern International Limited (Chiltern), a global contract research
organization, announced its latest collaboration with Tayside Academic Health
Sciences Centre (TAHSC), a joint venture between UK's NHS Tayside and the
University of Dundee. In this collaboration, Chiltern will partner with TAHSC
to conduct and support Proof of Concept and Translational Medicine studies.

Chiltern will draw upon many parts of TAHSC, including the Clinical
Research Centre (CRC) which is located on the same University Medical School
and hospital campus as Chiltern Early Phase and NHS Tayside's Clinical
Imaging and Interventional Centre (CIIC). The CRC is the hub for clinical
trial activity with links to additional satellite units in Tayside. Chiltern
and the CRC will focus on Proof of Concept studies in areas such as diabetes,
COPD, cardiovascular disease, neurological conditions and Hepatitis C.

The CIIC houses a sophisticated 3T MRI scanner and a PET/CT scanner. A
unique feature of the suite is an operating room situated between the MRI and
PET/CT scanners, allowing ready access to these important tools before,
during and after surgery. Ease of access to state of the art diagnostic
equipment and expertise, the availability of Key Opinion Leaders in many
disease areas as well as access to study subjects interested and available to
participate in these studies, make this an ideal setting for performance and
delivery of the highest caliber.

Glenn Kerkof, Chiltern CEO, stated, "This new partnership demonstrates
Chiltern's commitment to deliver high quality POC studies to our clients and
adding value to their drug development processes by combining our extensive
experience with world class academic-based research and expertise. We are
proud of this new collaboration and confident that the world class Key
Opinion Leaders in TAHSC will augment our expertise in our early phase
business."

Jill Belch, Professor, Tayside Research and Development Director,
commented, "Supporting the local research community and building strong
working relationships with industrial partners are key objectives for TAHSC.
This agreement will allow potential access to new drugs for our patients in
Tayside and allow our researchers to participate in a larger range of cutting
edge clinical studies."

About Chiltern

Chiltern has a dedicated forty-two bed clinical pharmacology unit located
in Ninewells Hospital and Medical School. Established in 1982, Chiltern has
performed more than 700 clinical pharmacology studies in all routes of
administration across major therapeutic areas. With more than 28 years of
experience, Chiltern has robust processes in place and its hospital-based
location provides a full suite of safety monitoring with 24/7 access to
hospital-based crash team and hospital specialists for therapeutic area
expertise and patient recruitment. Chiltern offers an extensive database of
healthy volunteers and other patient populations. For more information:
www.chiltern.com.

About TAHSC

The Scottish Academic Health Science Collaboration was launched in June
2009 and comprises four nodes based around NHS and University collaborations
in Tayside, Aberdeen, Glasgow and Edinburgh. The collaborative venture
between NHS Tayside and the University of Dundee - TAHSC was launched in
January 2010 to boost clinical research activity within Tayside. TAHSC
combines excellence in academia, clinical service delivery, research
management and education. Together NHS Tayside and the University of Dundee
employ 16,000 staff and have an annual turnover of over 1 billion pounds
Sterling. There is a wide range of joint expertise in research into cancer,
diabetes, cardiovascular disease, neuroscience, photobiology/dermatology, and
infection, inflammation and immunity. For more information:
www.tahsc.org.uk.

    Natalie Chong                             Susan Ojanen
    Marketing Director                        Marketing Associate
    Chiltern International Ltd.               Chiltern International Inc.
    171 Bath Road                             1241 Volunteer Parkway
    Slough                                    Suite 950
    Berkshire SL1 4AA                         Bristol, TN 37620
    UNITED KINGDOM                            USA
    Tel:  +44-0-1753-512-000                  Tel:  +1-423-968-9533
    Fax: +44-0-1753-511-116                   Fax: +1-423-968-3567
    Email: natalie.chong@chiltern.com         Email: susan.ojanen@chiltern.com

Natalie Chong, Marketing Director, +44-0-1753-512-000, Fax, +44-0-1753-511-116, natalie.chong at chiltern.com; or Susan Ojanen, Marketing Associate, +1-423-968 9533, Fax, +1-423-968 3567, susan.ojanen at chiltern.com, both of Chiltern International Ltd